The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma
Top Cited Papers
Open Access
- 10 October 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (56) , 96103-96116
Abstract
The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinomaKeywords
This publication has 29 references indexed in Scilit:
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Epidemiology of Renal Cell CancerHematology/Oncology Clinics of North America, 2011
- Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancerCancer and Metastasis Reviews, 2009
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewCancer Treatment Reviews, 2008
- Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma CellsCancer Research, 2008
- Ras, PI(3)K and mTOR signalling controls tumour cell growthNature, 2006
- mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates AktCancer Research, 2006
- Renal-Cell CarcinomaNew England Journal of Medicine, 2005
- 5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNABiochemistry, 1976
- The methylated constituents of L cell messenger RNA: Evidence for an unusual cluster at the 5′ terminusCell, 1975